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Xenopus embryogenesisThe formation of the dorsal–ventral (DV) and anterior–posterior (AP) axes, fundamental to the body plan of
animals, is regulated by several groups of polypeptide growth factors including the TGF-β, FGF, andWnt fam-
ilies. In order to ensure the establishment of the body plan, the processes of DV and AP axis formation must
be linked and coordinately regulated. However, the molecular mechanisms responsible for these interactions
remain unclear. Here, we demonstrate that the forkhead box transcription factor FoxB1, which is upregulated
by the neuralizing factor Oct-25, plays an important role in the formation of the DV and AP axes. Overexpres-
sion of FoxB1 promoted neural induction and inhibited BMP-dependent epidermal differentiation in ectoder-
mal explants, thereby regulating the DV patterning of the ectoderm. In addition, FoxB1 was also found to
promote the formation of posterior neural tissue in both ectodermal explants and whole embryos, suggesting
its involvement in embryonic AP patterning. Using knockdown analysis, we found that FoxB1 is required for
the formation of posterior neural tissues, acting in concert with the Wnt and FGF pathways. Consistent with
this, FoxB1 suppressed the formation of anterior structures via a process requiring the function of XWnt-
8 and eFGF. Interestingly, while downregulation of FoxB1 had little effect on neural induction, we found
that it functionally interacted with its upstream factor Oct-25 and plays a supportive role in the induction
and/or maintenance of neural tissue. Our results suggest that FoxB1 is part of a mechanism that ﬁne-tunes,
and leads to the coordinated formation of, the DV and AP axes during early development.ki).
rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The establishment of the body plan of the amphibian embryo occurs
during blastula and gastrula stages in response to signaling by several
groups of polypeptide growth factors including those of the TGF-β,
FGF, and Wnt families (De Robertis et al., 2000; Harland and Gerhart,
1997; Heasman, 2006; Muñoz-Sanjuán and H.-Brivanlou, 2001; Niehrs,
2010; Stern, 2005). The basic outline of the body plan is manifested in
the development of the ectodermal tissues. The Xenopus embryonic ec-
toderm becomes subdivided into neural and epidermal tissues along
the dorsal–ventral (DV) axis, and the neural tissues are patterned to
form the fore-, mid- and hind-brain, and spinal cord along the anterior–
posterior (AP) axis (Doniach, 1995; Gamse and Sive, 2000; Gould and
Grainger, 1997; Holland, 2002; Slack and Tannahill, 1992; Stern et al.,
2006). In order to ensure the establishment of the body plan, genetic
and developmental mechanisms for coordinating the formation of the
DV and AP axes must exist. Several genes have been proposed to act
as potential molecular links connecting the formation of DV and APaxes during early embryogenesis (Cruz et al., 2010; De Robertis, 2008;
Fuentealba et al., 2007; Gestri et al., 2005; Lagutin et al., 2003; Niehrs,
2010; Piccolo et al., 1999; Sapkota et al., 2007), but the exact molecular
mechanisms responsible for these interactions largely remain to be
elucidated.
Bone morphogenetic proteins (BMPs) are members of the
TGF-β family that play a central role in the determination of ecto-
dermal cell fates by promoting epidermis formation and simulta-
neously by inhibiting neural differentiation at the ventral side of
the ectoderm (Kishigami and Mishina, 2005; Massagué and Chen,
2000; Muñoz-Sanjuán and H.-Brivanlou, 2001; Whitman, 2008).
BMPs bind to type I and type II receptors at the cell surface.
Upon ligand binding, the type II receptor activates the type I receptor
which then transduces the signal by phosphorylating the BMP receptor-
associated Smads (R-Smads) Smad1/5/8 at their C-terminal serine
residues (Feng and Derynck, 2005; Moustakas and Heldin, 2009;
Wu and Hill, 2009). The C-terminally phosphorylated Smad1/5/8
(pSmad1/5/8) form a complex with the Co-Smad, Smad4, and sub-
sequently translocate into the nucleus. There, the complex regulates
the expression of BMP target genes by recruiting transcription co-
activators or co-repressors. The termination of signaling appears to
be in part dependent on the dephosphorylation of Smad1/5/8 by
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et al., 2006). The resulting unphosphorylated Smad1/5/8 are
recycled back into the cytoplasm to allow re-phosphorylation by
the active receptor complexes, providing a sensing mechanism in
which cells constantly monitor the level of BMP signal input.
On the dorsal side of the embryo extracellular BMP antagonists
(Noggin, Chordin and Follistatin), emanating from the organizer, in-
duce neural tissue by interfering with the activation of BMP receptors
(De Robertis and Kuroda, 2004; Harland and Gerhart, 1997; Khokha
et al., 2005; Muñoz-Sanjuán and H.-Brivanlou, 2002). It has also
been shown that the early phase of neural induction involves ﬁbroblast
growth factors (FGFs) and insulin-like growth factors (IGFs) that antag-
onize the BMP pathway at multiple levels including BMP gene expres-
sion and the stability/subcellular localization of Smads (Delaune et al.,
2005; Fuentealba et al., 2007; Kretzschmar et al., 1999; Linker andStern, 2004; Pera et al., 2003; Sater et al., 2003; Wilson et al., 2000).
While it is not precisely determined when and how the AP patterning
of the neuroectoderm occurs, one model predicts that anterior neural
tissue, which eventually becomes the fore- andmid-brain, is initially in-
duced by inhibition of BMP signaling and subsequently posteriorized to
form the hindbrain and spinal cord by members of the FGF and Wnt
families of growth factors and by retinoic acids (Doniach, 1995;
Gamse and Sive, 2000; Maden, 2002; Niehrs, 2010; Stern et al., 2006;
Wilson and Edlund, 2001).
The forkhead box (Fox) gene family is known to be involved in
regulation of embryonic development, tumorigenesis, longevity and
immune control (Carlsson and Mahlapuu, 2002; Hannenhalli and
Kaestner, 2009; Jonsson and Peng, 2005; Pohl and Knöchel, 2005).
All members of this family share a characteristic DNA-binding domain
with a winged helix motif (Carlsson and Mahlapuu, 2002; Weigel and
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identiﬁed to date (Kaestner et al., 2000; http://www.genenames.org/
genefamilies/FOX). Expression of mouse FoxB1, referred to as fkh-5
(Kaestner et al., 1996), HFH-E5.1 (Ang et al., 1993) or Mf3 (Labosky
et al., 1997), was found in posterior regions of early embryos, and at
later stages, localized to speciﬁc regions such as the midbrain, spinal
cord and hypothalamus (Alvarez-Bolado et al., 1999; Kloetzli et al.,
2001; Wehr et al., 1997; Zhao et al., 2007). Mice deﬁcient in FoxB1
(previously referred to as TWH, Mf3, and Fkh5) have complex pheno-
types, including reduced posterior tissue formation, severe open neu-
ral tube defects and an impaired hypothalamus (Alvarez-Bolado et al.,
2000; Dou et al., 1997; Kloetzli et al., 2001; Labosky et al., 1997;
Radyushkin et al., 2005; Wehr et al., 1997). In the frog embryo,
FoxB1 (previously referred to as fkh5) is expressed in the posterior
dorsal ectoderm of the gastrula, and subsequently in the diencepha-
lon, mid- and hind-brain, and spinal cord (Gamse and Sive, 2001).
The expression of FoxB1 is induced by the posteriorizing factors FGF
andWnt, and thus FoxB1 is implicated in the AP patterning of neural tis-
sues.While FoxB1has been used as a neuralmarker gene in experimental
model animals like mouse (Alvarez-Bolado et al., 1999; Zhao et al., 2008)
and zebraﬁsh (Grinblat et al., 1998; Nguyen et al., 1998) embryos, the
phenotype of mouse FoxB1 mutants is complex and the roles of FoxB1
in vertebrate neural induction and patterning remain unclear.
Previously, we showed that a POU class V transcription factor Oct-
25 acts as a transcriptional activator to inhibit BMP-dependent tran-
scription, suggesting a mechanism by which Oct-25 suppresses BMP
responses via transcriptional activation of its downstream target
genes (Takebayashi-Suzuki et al., 2007). In the present study, we an-
alyzed the roles of Xenopus FoxB1, which is upregulated by Oct-25, in
the DV and AP patterning of the Xenopus ectoderm. We show that
FoxB1 promotes neural induction and inhibits epidermal differentia-
tion by suppressing BMP signaling, thereby regulating the DV pat-
terning of the ectoderm. In addition, we found that FoxB1 is
required for the formation of posterior neural tissues by acting to-
gether with the Wnt and FGF pathways, suggesting that FoxB1 is
also involved in AP patterning of the embryos. Moreover, FoxB1 upre-
gulates the expression of XWnt-8 and FGFs, and the suppression of an-
terior structures by FoxB1 partially requires the function of XWnt-
8 and eFGF. Interestingly, FoxB1 is dispensable for neural induction
per se, but functionally interacts with its upstream factor Oct-25 toFig. 1. Xenopus FoxB1, acting downstream of Oct-25, promotes neural induction and suppre
activated by the Oct-25 transcription factor. GR-Oct-25mRNA (1000 pg) was injected into th
stage, treated with or without dexamethazone (DEX) to activate Oct-25, cultured until the e
indicate whole embryo RNA processed in the presence or absence of reverse transcriptase,
motes neural induction and inhibits epidermal differentiation. GR-FoxB1 mRNA (500 pg and
explants were isolated at the blastula stage, treated with DEX to activate FoxB1 and culture
semi-quantitative RT-PCR. FoxB1 induced the expression of neural markers Sox2 and SIP1 w
sion of the mesodermal marker muscle actin was not induced by FoxB1 activation. (C) FoxB
type I receptor (CA-BMPR) and promotes Sox2 gene expression. The changes in the gene exp
conﬁrmed by quantitative real-time PCR (QPCR) (lower panel) using the same RNA sample
150 pg) were injected alone or together with GR-FoxB1 mRNA (1000 pg) into the animal
and dissociated for 6.5 h (lanes 4–15). Cells were treated with DEX to activate FoxB1 durin
dicates intact ectodermal cells obtained from uninjected embryos. The QPCR data are show
FoxB1 decreases endogenous levels of phosphorylated Smad1/5/8 in Xenopus ectodermal c
the animal pole of 4- to 8-cell stage embryos. Embryos were treated with DEX and ecto
stage (st. 10.5). Whole cell lysates from explants were immunoblotted with anti-phosph
FoxB1 was tagged at the C-terminus with the HA epitope. Tubulin was used as a loading co
Smad8 (Smad8AAVA) rather than a phospho-mimicking mutant form of Smad8 (Smad8SEV
of expression constructs (Myc-tagged FoxB1 and different constructs of Flag-tagged Smad8
cells with anti-FLAG antibodies, and the immunoprecipitates were then immunoblotted (IB
indicated antibodies (the lower two panels). (F) Wild-type FoxB1 is localized to the nuc
anti-Myc antibody (magenta, left panel). Nuclei were visualized with Hoechst 33342 (blue, m
of FoxB1 on the subcellular localization of Smad8AAVA in Xenopus ectodermal cells. Dissoc
panel) or both FLAG-Smad8AAVA andMyc-GR-FoxB1mRNA (lower panel), were immunostai
with Hoechst 33342 (blue). In the absence of FoxB1, Smad8AAVA was localized to both the
cumulated in the nucleus (lower panels). Scale bar, 10 μm. (H) Summary of data from indepe
nucleus was compared with that in the cytoplasm and scored as follows: no (no signiﬁcant
bers of Smad8AAVA-positive cells analyzed in independent ﬁelds are indicated below the bpromote neural development. Taken together, our results suggest
that FoxB1 plays an important role in the formation of DV and AP
axes and could be involved in a mechanism coordinating these axes
during early embryogenesis.
Materials and methods
Embryo manipulations, microinjection of morpholino antisense oligo-
nucleotides (MO) and mRNAs
Preparation and injection of Xenopus laevis embryos and the disso-
ciated cell assay of the ectodermal were carried out as previously
described (Suzuki et al., 1997a; Takebayashi-Suzuki et al., 2007).
Embryos were staged according to Nieuwkoop and Faber (1967).
Dexamethazone (DEX) treatments were performed as described
previously (Takebayashi-Suzuki et al., 2007). Dorsal ectodermal explants
were isolated at late gastrula stage (st. 12.5) by carefully removing the
ectodermal layer from the mesodermal layer with an eyebrow hair
knife in 1XLCMR (43 mM NaCl, 0.85 mM KCl, 0.37 mM CaCl2, 0.19 mM
MgCl2, 5 mM HEPES). The explants were transferred to 0.5XMMR and
cultured as described previously (Takebayashi-Suzuki et al., 2007). Anti-
sense morpholino oligonucleotides (MO) and the standard control MO
(Cont MO) were obtained from Gene Tools (Philomath, USA). The
sequences of the MO against FoxB1 are as follows: FoxB1 MO, 5′-
AGG TGT TTC TTC CAG GAC GAG GCA T -3′; 6-mismatched MO
(6mis FoxB1 MO), 5′- AGG TcT TTg TTC CAc Gag GAc GgA T -3′;
FoxB1 MO2, 5′- AGG TGT TTC TCG CAG GGC GAG GCA T -3′;
FoxB1MO3, 5′- CGA GGC ATC TTC ACT GGCAAA CAGG -3′. The location
of MO relative to FoxB1 mRNA is shown in Supplemental Fig. 5. The
sequence of the MO against FoxB2 is 5′- ACG AGC TCT TCC CTG GCC
GGG GCA T -3′, and the location of FoxB2 MO relative to FoxB2 mRNA
is shown in Supplemental Fig. 7. The sequences of following MOs
were obtained from published literatures: Oct-25 MO (Takebayashi-
Suzuki et al., 2007), XWnt-8 MO (Lee et al., 2006), eFGF MO (Fisher
et al., 2002) and FGF3 MO (Park and Saint-Jeannet, 2008). Capped
mRNAs were synthesized with a mMESSAGE mMACHINE kit
(Ambion, USA). In vitro translation of synthetic mRNA was carried
out using the Speed Read lysate kit (Novagen) and SDS-polyacrylamide
gel electrophoresis (SDS-PAGE) was performed using standard
methods.sses BMP-dependent epidermal differentiation. (A) The expression of Xenopus FoxB1 is
e animal pole of 4-cell stage embryos. Ectodermal explants were isolated at the blastula
arly gastrula stage (st. 10.5), and analyzed by semi-quantitative RT-PCR. Emb and –RT
respectively. Histone was used as a loading control. (B) Overexpression of FoxB1 pro-
1000 pg) was injected into the animal pole of 4- to 8-cell stage embryos. Ectodermal
d until early neurula stage (st. 15). The expression of marker genes was determined by
ith a moderate reduction in the expression of epidermal keratin (lanes 4 and 5). Expres-
1 inhibits epidermal keratin gene expression induced by a constitutively activated BMP
ression proﬁle were determined by semi-quantitative RT-PCR (upper panel) and further
s shown in the upper panel. Increasing amounts of CA-BMPR mRNA (9, 19, 38, 75 and
pole of 2-cell stage embryos. Ectodermal explants were isolated at the blastula stage,
g the dissociation, reaggregated and cultured until neurula stages (st. 21). “Intact” in-
n as arbitrary units normalized to ornithine decarboxylase (ODC) gene expression. (D)
ells. Increasing amounts of GR-FoxB1 mRNA (500 pg and 1000 pg) were injected into
dermal explants were isolated at the blastula stage, cultured until the early gastrula
o Smad1/5/8, anti-Smad1/5/8, anti-HA and anti-Tubulin antibodies, respectively. GR-
ntrol. (E) FoxB1 interacts preferentially with a non-phosphorylatable mutant form of
E) and wild-type Smad8. HeLa cells were transfected with the indicated combination
). The Flag-tagged Smad8 constructs were immunoprecipitated (IP) from transfected
) with anti-Myc antibodies (top panel). Input extracts were immunoblotted with the
leus of HeLa cells. Transfected cells with Myc-FoxB1 DNA were immunostained with
iddle panel). The merged image is shown in the right panel. Scale bar, 10 μm. (G) Effect
iated ectodermal cells from embryos injected with FLAG-Smad8AAVA mRNA alone (top
ned with anti-FLAG (green) and anti-Myc (magenta) antibodies. Nuclei were visualized
cytoplasm and nucleus (upper panels), whereas Smad8AAVA together with FoxB1 ac-
ndent experiments presented in (G). The intensity of FLAG-Smad8AAVA staining in the
difference to that in the cytoplasm), weak, moderate, or strong nuclear staining. Num-
ars.
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To identify genes downstream of Oct-25, Xenopus embryos were
injected at the 8-cell stage with mRNA encoding GR-Oct-25, a hor-
mone-inducible version of Oct-25 (Takebayashi-Suzuki et al., 2007).
Explants from stage 9 embryos were treated with or without DEX
until the sibling embryos reached stage 10.5, when they were used
for RNA extraction. Total RNA from about 100 explants was puriﬁed
using the AGPC method (Chomczynski and Sacchi, 1987). Microarray
analysis was carried out as previously described (Chung et al., 2004).
The resulting data were analyzed using the statistical program Cyber-
T (http://cybert.microarray.ics.uci.edu/; Baldi and Long, 2001; Long et
al., 2001). We repeated the experiments twice, including injection,
isolation of explants and extraction of RNA. An aliquot of each RNA
sample was assayed for the expression of Msx1 to conﬁrm the activa-
tion of Oct-25 (data not shown; Takebayashi-Suzuki et al., 2007). The
microarray data were deposited in the Gene Expression Omnibus
(GEO) database (www.ncbi.nlm.nih.gov/geo/) under accession num-
ber GSE24562, and processed data are also available as Supplemental
ﬁle 1. Through two independent microarray analyses, we identiﬁed 4
genes whose expression was signiﬁcantly upregulated by Oct-25
(fold N1.5; Supplemental Table S1). Of these, upregulation of FoxB1
(Gamse and Sive, 2001), FoxI1e (Solomon et al., 2003; Suri et al.,
2005) and Sox2 (Mizuseki et al., 1998) expression was conﬁrmed by
semi-quantitative PCR (Fig. 1A. and data not shown). Identiﬁcation
of Sox2, a known downstream gene of Oct-25 (Cao et al., 2006), in
this screening indicates that the microarray analysis worked properly.
We focused on FoxB1 for further study because its expression is localized
in the neural plate and its role during early Xenopus embryogenesis has
not been well documented.
Plasmids
A Xenopus laevis FoxB1 cDNA (NIBB clone nameXL014n21, GenBank
accession number NM_001088367.1) in pBlueScript SK(−) was
obtained from the XDB3 cDNA collection (http://xenopus.nibb.ac.jp).
pDH105-GR-FoxB1, pDH105-WT-FoxB1, pDH105-Nmut-FoxB1, pcDNA3-
MycFoxB1 and pDH105-Myc-GR-FoxB1weremade by a PCR-based strat-
egy. The following primer combinations and restriction enzymes were
used: pDH105-GR-FoxB1, FoxB1GR (U) (5′- CG GGA TCC ATG CCT CGT
CCT GGA AGA AAC -3′) and FoxB1GR (D) (5′- CCG CTC GAG GTG TAC
AGC CAC AGA GAG CAG -3′), digested with BamHI and XhoI; pDH105-
WT-FoxB1, FoxB1GR (U) and FoxB1CL (D) (5′- CCG CTC GAG TCA GTG
TAC AGC CAC AGA GAG -3′), digested with BamHI and XhoI; pDH105-
Nmut-FoxB1, Nmut-FoxB1 (U) (5′- CG GGA TCC ATG CCa CGa CCa GGt
AGgAAt ACC TAC AGCGAC CAG AAGCC -3′) and FoxB1 CL (D), digested
with BamHI and XhoI; pcDNA3-Myc FoxB1, Myc-FoxB1 (U) (5′- G GAA
TTC ATG CCT CGT CCT GGA AGA AAC ACC -3′) and Myc-FoxB1 (D) (5′-
GCT CTA GAC TCA GTG TAC AGC CAC AGA GAG -3′), digested with
EcoRI and XbaI; pDH105-Myc-GR-FoxB1, T7 and FoxB1GR (D), digested
with BamHI andXhoI. The PCR fragmentswere digestedwith restriction
enzymes as indicated above and subcloned into appropriate expression
vectors: pDH105-GRHA (Takebayashi-Suzuki et al., 2003), pDH105
(a gift from Dr. R. Harland), Myc-pcDNA3 (Imamura et al., 1997).
For expression in HeLa cells, pcDNA3-FLAG-Smad8, pcDNA3-FLAG-
Smad8SEVE and pcDNA3-FLAG-Smad8AAVA were also generated by a
PCR-based strategy using pcdef3-F-Smad8 (a gift from Drs. Watabe
and Miyazono) as a template. The PCR fragments were digested with
BamHI and XbaI, and subcloned into pcDNA3 vectors. The following
primer combinations were used: pcDNA3-FLAG-Smad8, 3xFLAG(U)
(5′- CG GGA TCC ATG GAC TAC AAA GAC CAT GAC GGT GAT TAT AAA
GAT CAT GAC ATC GAC TAC AAG GAC GAT GAT GAC AAG -3′) and
SP6; pcDNA3-FLAG-Smad8SEVE, 3xFLAG(U) and Smad8SEVE-XbaI (5′-
G TCT AGA TTA AGC CAC TGC AGC AAT GGG GTT ATG TGG AGA GCC C
-3′); pcDNA3-FLAG-Smad8AAVA, 3xFLAG(U) and Smad8AAVA-XbaI
(5′- G TCT AGA TTA CTC CAC TTC AGA AAT GGG GTT ATG TGG AGAGCC C -3′). For expression in Xenopus ectodermal cells, pDH105-FLAG-
Smad8AAVA was generated by subcloning a BamHI/XbaI fragment
from pcDNA3-FLAG-Smad8AAVA into pDH105 vector. pCSKA-XWnt-8 and
pBlueScript II KS(−)-XWnt-8 were generated by subcloning XWnt-
8 cDNA from pSP64T-XWnt-8 (Christian et al., 1991) into pCSKA and
pBlueScript II KS (−) vector, respectively. Other plasmids used for
mRNA synthesis were pCS2-FGFR-K562E (Neilson and Friesel, 1996),
pCS2-TVGR (Darken and Wilson, 2001), pSP64T-ΔBMPR (Suzuki et al.,
1995), pCS-dkk-1 (Glinka et al., 1998), pSP64TBX-CA-ALK2 for CA-BMPR
expression (Suzuki et al., 1997a), pSP64T-eFGF (Isaacs et al., 1995),
pSP6nucβgal (Smith and Harland, 1991) and pDH105-GR-Oct-25
(Takebayashi-Suzuki et al., 2007).
Semi-quantitative RT-PCR and quantitative real-time PCR (QPCR)
Capped mRNAs synthesized from the plasmids were injected in the
animal pole of 4- to 8-cell embryos. Ectodermal explants isolated at the
blastula stage were subjected to RT-PCR analysis at the indicated stage
as described previously (Wilson and Hemmati-Brivanlou, 1995). For
quantitative real-time PCR (QPCR), reverse transcription was performed
using PrimeScript RT reagent (Takara, Tokyo, Japan). PCR reactions
were then carried out with SYBR Premix Ex Taq II (Perfect Real Time)
and a thermal cycler Dice Real Time System (Takara, Tokyo, Japan).
Primers used in the semi-quantitative RT-PCR were as described previ-
ously: FoxB1 (fkh5; Gamse and Sive, 2001), En2, HoxB9 (XlHbox-6; also
used inQPCR analysis) andMuscle actin (Hemmati-Brivanlou andMelton,
1994), Histone H4 (Suzuki et al., 1997b), Msx1 (Suzuki et al., 1997c),
XAG1 (Suzuki et al., 1995), epidermal keratin (Wilson and Hemmati-
Brivanlou, 1995), Krox20, Otx2 and Sox2 (also used in QPCR analysis; De
Robertis' laboratory home page, http://www.hhmi.ucla.edu/derobertis/).
Other primer sequences for semi-quantitative RT-PCR were as follows:
FoxB2, 5′- CCC AGC CAA ATA AGC AAC AT -3′ and 5′- ACT GGT GGA
AGA GAC GCA GT -3′; SIP1, 5′- ACA CGG TCA GTG AAG AAT CC -3′ and
5′- GGC AAA GTT CTT CAG GGG CT -3′. Primers used in QPCR were
as described previously: Ornithine decarboxylase (ODC) (Cao et al.,
2006), En2 (Yokota et al., 2003), Wnt-1, XWnt-8, FGF-3 and FGF8
(Park and Saint-Jeannet, 2008). Other primer sequences for QPCR were
as follows: eFGF, 5′- TTA CCG GAC GGA AGG ATA -3′ and 5′- CCT CGA
TTC GTA AGC GTT -3′; Wnt-3A, 5′- GAG ATT ATG CCG AGC GTA GC -3′
and 5′- AGA CCT GGT TAC GGC AAA TG -3′; HoxC6, 5′- CGG CAG ATC
AAA ATC TGG TT -3′ and 5′- AGG AAG CCT TAG TGG GGT GT -3′. The
condition of QPCR was 95 °C for 10 s followed by 45 cycles at 95 °C for
5 s, 58 °C for 10 s, and 72 °C for 30 s. All experiments included a negative
control, and a serial dilution of control embryo RNA was used to create a
standard curve. All values were normalized to the level of ODC in each
sample.
Cell culture, transfection, co-immunoprecipitation (co-IP) and immuno-
blotting (IB)
HeLa cells were maintained in Eagle's minimum essential medium
(Nissui, Tokyo, Japan) supplemented with 10% fetal bovine serum
(FBS), penicillin and streptomycin (GIBCO® Invitrogen, USA). Cells
were transfected with expression constructs for Flag-tagged Smads
and/or Myc-tagged FoxB1 using FuGENE HD Transfection reagent
(7:2 reagent to DNA ratio; Roche Diagnostics, Basel, Switzerland)
according to the manufacturer's protocol. At 42 h after transfection,
cells were washed, scraped and solubilized in Lysis buffer containing
20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM phe-
nylmethylsulfonyl ﬂuoride (PMSF), phosphatase inhibitor cocktail at
a dilution of 1:100 (Nakalai Tesque, Tokyo, Japan), 20 μg/ml aprotinin
(Roche) and 10 μMMG132 (Calbiochem), a proteasome inhibitor. The
cell extracts were lysed by 10 passages through a 21-gauge needle.
After 30 min on ice, the cell lysates were centrifuged at 15,000 rpm
for 15 min at 4 °C and the supernatant was preabsorbed with protein
G Sepharose beads (Santa Cruz Biotechnology, California, USA). The
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supernatant was incubated with the anti-Flag M2 monoclonal
(Sigma) for 2 h, followed by incubation with protein G Sepharose
beads for 2 h at 4 °C. Unbound proteins were removed by washing
three times with the Lysis buffer. The bound proteins were eluted
by boiling for 5 min in SDS sample buffer (125 mM Tris–HCl, pH 6.8,
4% SDS, 20% Glycerol, 0.04% bromophenol blue) containing 10% 2-
mercaptoethanol, and subjected to SDS-PAGE. Proteins were then
transferred to FluoroTrans® polyvinylidene diﬂuoride (PVDF) Mem-
brane (Pall, USA) and the blots were incubated with 5% skim milk in
Tris-buffered saline containing Tween20 (TBS-T; 20 mM Tris–HCl,
pH 7.6, 137 mM NaCl, 0.05% Tween20) for 1 h at 24 °C. Then, the
blots were incubated overnight at 4 °C with the anti-Myc polyclonal
antibody as primary antibody (code 2272, Cell Signaling Technology,
USA). After washing with TBS-T, the blots were incubated with HRP-
conjugated anti-rabbit antibody for 1.5 h at 24 °C, and secondary an-
tibody was detected using the Pierce Super Signal chemiluminescent
detection system (Thermo Fisher Scientiﬁc, USA). For reprobing, the
blot was stripped according to the manufacturer's protocol. The cell
lysates were also directly subjected to immunoblotting to check the
expression levels of FLAG-Smads and Myc-FoxB1.
For immunoblotting of Xenopus ectodermal cells, 12 explants from
injected embryos were solubilized at st. 10.5 by pipetting in 60 μl of
Lysis buffer containing 20 mMTris–HCl, pH7.5, 150 mMNaCl, 1% Triton
X-100, phosphatase inhibitor cocktail at a dilution of 1:100 (Nakalai
Tesque, Tokyo, Japan), and complete mini protease inhibitor (Roche
Diagnostics, Basel, Switzerland). After 15 min on ice, the cell lysates
were centrifuged at 5,000 rpm for 5 min at 4 °C, and the supernatant
was subjected to immunoblotting using the anti-Smad1/5/8 (code N18,
Santa Cruz), anti-pSmad1/5/8 (code 9511, Cell Signaling Technology,
USA), or anti-α-tubulin (code DM1A, Sigma) as a loading control. For
detecting GR-FoxB1, anti-HA-POD (code 3F10, Roche Diagnostics) was
used as a primary antibody.Immunocytochemical analysis of Xenopus ectodermal cells and cultured
HeLa cells
Ectodermal explants were isolated from embryos injected with
the indicated RNA at the blastula stage and dissociated for about
1 h. Dissociated cells were seeded onto glass coverslips coated with
0.001% ﬁbronectin (SIGMA F1141, USA) in 0.5X MMR. When sibling
embryos reached st. 10.5, the cells were ﬁxed with cold methanol
on ice (gradual increase in concentration of methanol from 25% to
100%, 5 min/step), followed by washing with PBS and blocking with
PBS containing 10% normal goat serum and 1% BSA. Primary anti-
bodies were incubated for 1.5 h at 24 °C using the following dilutions:
anti-FLAG monoclonal antibody (1:1000, code M2, Sigma) or anti-
Myc polyclonal antibody (1:500, code 2272, Cell Signaling Technolo-
gy, USA). Bound primary antibodies were detected by incubation
with Alexa-488-conjugated anti-mouse or Alexa-568-conjugated
anti-rabbit secondary antibody (Invitrogen, USA) for 30 min at 24 °C
together with Hoechst 33342 (Invitrogen, USA). In order to suppress
autoﬂuorescence, after washing with cold PBS, ectodermal cells
were incubated with 0.05% Eriochrome Black T (code B015, Dojindo,
Tokyo, Japan) in PBS for 5 min at 24 °C. HeLa cells transfected with
pcDNA3-Myc-FoxB1 plasmid were ﬁxed with 3.7% formaldehyde for
15 min at 24 °C, permeabilized with 0.25% Triton X-100 in PBS.
Anti-Myc monoclonal antibody (1:500, code 9E10, Santa Cruz)
and Alexa-568-conjugated anti-mouse antibody (Invitrogen, USA)
were used as primary and secondary antibodies, respectively. For
staining of cell nuclei, Hoechst 33342 (Invitrogen, USA) was used
together with secondary antibodies. Coverslips were mounted in
Fluoroguard (BioRad, USA) and the stained cells were imaged
using a confocal laser scanning microscope (FV1000-D, Olympus,
Japan).Lineage tracing and whole-mount in situ hybridization
Lineage tracing and whole-mount in situ hybridization was carried
out essentially as described previously (Takebayashi-Suzuki et al.,
2007). For two-color in situ hybridization, ﬂuorescein-labeled probes
were visualized by the color reaction using 0.11 μg/μl of Fast Red TR
Salt 1,5-naphthalenedisulfonate salt (Fast Red) and 0.35 μg/μl
5-bromo-4-chloro-3indolyl-phosphate (BCIP) solution (Hurtado and
Mikawa, 2006). For probe synthesis, template plasmids, restriction
enzymes for linearization, and RNA polymerase for transcription
were listed as follows: pBlueScript SK(−)-FoxB1, BamHI, T7; pBlue-
Script II KS(−)-XWnt-8, BamHI, T3; pBS-KS Xotx2 HD, EcoRI, T3 (Blitz
and Cho, 1995); En2-pBS+KS, XbaI, T3 (Hemmati-Brivanlou et al.,
1991); pBlueScript KS-FGF8, XbaI, T3 (Christen and Slack, 1997);
eFGF, XhoI, SP6 (Pownall et al., 1996); FGF3, ClaI, T3 (Lombardo et
al., 1998); Rx2A, XhoI, SP6 (a gift from Dr. De Robertis); p1 (HoxB9),
EcoRI,T7 (Fritz and De Robertis, 1988); Sox2, XhoI, T7 (Mizuseki et
al., 1998); MyoD, BamHI, SP6 (Hopwood et al., 1989); Oct-25, ClaI, T3
(Takebayashi-Suzuki et al., 2007); p10 (HoxC6, XlHbox1), BamHI, T7
(Fritz and De Robertis, 1988); Krox20, EcoRI, T7 (Bradley et al. 1993)
and epidermal keratin, HindIII, SP6 (Jonas et al., 1985).
Results
Xenopus FoxB1, a downstream gene of Oct-25, promotes neural induc-
tion and suppresses BMP-dependent epidermal differentiation
Previously,we showed that theXenopus POU class V transcription fac-
tor Oct-25 decreases the competence of the ectoderm to respond to BMP
signaling and plays an important role in the establishment of the central
nervous system during early embryogenesis (Takebayashi-Suzuki et al.,
2007). We also found that Oct-25 functions as a transcriptional activator,
raising the possibility that it promotes the expression of downstream
genes that inhibit BMP signaling in the ectoderm. These observations
led us to identify Xenopus FoxB1, previously called fkh5 (Gamse and
Sive, 2001), as a gene that is transcriptionally activated by Oct-25 (see
Materials and methods). FoxB1 is of particular interest because it has
been reported that its expression is predominantly localized to the neu-
roectoderm during neurula stages, with some degree of overlap with
Oct-25 (Cao et al., 2004; Gamse and Sive, 2001; Morrison and Brickman,
2006; Takebayashi-Suzuki et al., 2007; Supplemental Fig. 1). As shown
in Fig. 1A, the induction of FoxB1 gene expression by Oct-25 was con-
ﬁrmed using semi-quantitative RT-PCR analysis. The expression of
FoxB2 (previously referred to as XFD-5; Pohl et al., 2002), which shows
57% identity with FoxB1 at the amino acid level, was not signiﬁcantly in-
duced byOct-25 overexpression, indicating speciﬁc induction of FoxB1 by
Oct-25. Because the role of FoxB1 during vertebrate early neural develop-
ment has not been fully studied previously, especially in terms of func-
tional relationships with growth factor signals responsible for
embryonic patterning, we next analyzed the function of FoxB1 in neural
induction and patterning of early Xenopus embryos.
We ﬁrst tested whether overexpression of FoxB1 neuralizes the
Xenopus ectoderm and suppresses epidermal differentiation. We
used a hormone-inducible FoxB1 (GR-FoxB1) to avoid any effect of
its precocious overexpression before the blastula stage, as the expres-
sion of FoxB1 is known to start from early gastrula stages (Gamse and
Sive, 2001). As shown in Fig. 1B, overexpression of GR-FoxB1 followed
by DEX treatment induced the expression of the neural markers Sox2
and SIP1 with a moderate reduction in the expression of epidermal
keratin (lanes 4 and 5). Expression of the mesodermal marker muscle
actin was not induced by FoxB1 activation, indicating that the neura-
lization caused by FoxB1 did not result secondarily from induction of
dorsal mesoderm differentiation. In the absence of DEX, we con-
ﬁrmed that GR-FoxB1 remained unable to induce neural markers
(Supplemental Fig. 2). We also conﬁrmed that wild-type FoxB1 (WT-
FoxB1) is capable of inducing neural markers in a similar manner,
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We therefore used GR-FoxB1 instead ofWT-FoxB1 in subsequent exper-
iments, except for those relating to the rescue of the loss-of-function
phenotype of FoxB1 (Figs. 5 and 7). It has been shown that loss-of-
function of Oct-25 suppresses formation of the Sox2-positive neural
plate (Takebayashi-Suzuki et al., 2007). Overexpression of FoxB1 was
able to partially rescue the neural plate defects caused by inhibition of
Oct-25 (Supplemental Fig. 3). This conﬁrms that FoxB1 functions, at
least in part, downstream of Oct-25 during neural development.
The results described above indicate that FoxB1 promotes neural de-
velopment and concomitantly suppresses epidermal differentiation in
the ectoderm. This raises the possibility that FoxB1 suppresses BMP
signaling, which plays an essential role in the determination of neural/
epidermal cell fates during gastrulation (Kishigami and Mishina, 2005;
Massagué and Chen, 2000; Muñoz-Sanjuán and H.-Brivanlou, 2001;
Whitman, 2008). To examine this, we utilized the dissociated ectoder-
mal cell assay, a well-established assay for measuring the responses ofFig. 2. FoxB1 cooperates with inhibition of BMP signaling to promote commitment to neur
BMP signaling (dominant negative BMP receptor, ΔBMPR) to expand the expression of the n
(arrowheads, D). Together with β-galactosidase (β-gal) mRNA, GR-FoxB1 (250 pg) and ΔBM
tomeres of 8-cell stage embryos as indicated. The expression of Sox2 (A, C, and E) and epiderm
stained in red. The injected side of the embryo is indicated by brackets. All panels show do
expression domain of Sox2. Summary of phenotypes shown in (A), (C) and (E). Each exper
do not cooperatively expand the expression domain of En2. Photographs of stained embryoectodermal cells to exogenous BMP signaling (Suzuki et al., 1997a;
Takebayashi-Suzuki et al., 2007; Wilson and Hemmati-Brivanlou,
1995). When increasing amounts of an activated form of a BMP type I
receptor (CA-BMPR) were overexpressed together with FoxB1 in ecto-
dermal cells, FoxB1 suppressed the expression of epidermal keratin
and augmented Sox2 expression (upper panel in Fig. 1C, lanes 10–15).
These changes in the gene expression proﬁle were conﬁrmed by quan-
titative real-time RT-PCR (QPCR, lower panel in Fig. 1C) using the same
RNA samples as used for the analysis shown in the upper panel. In addi-
tion to themarker gene expression, we also conﬁrmed that overexpres-
sion of FoxB1 reduces the levels of endogenous pSmad1/5/8, an
indicator of ongoing BMP signaling, during early gastrula stages
(Fig. 1D). These results suggest that FoxB1 suppresses BMP-dependent
epidermal differentiation and thereby promotes neural induction dur-
ing gastrulation.
We next determined the mechanism by which FoxB1 inhibits BMP
signaling during embryogenesis. Our results indicate that FoxB1al fate at the expense of epidermal fate. (A–F) FoxB1 cooperates with the inhibition of
eural plate marker Sox2 (arrowheads, C) at the expense of epidermal keratin expression
PR mRNA (125 pg) were injected unilaterally into both dorsal and ventral animal blas-
al keratin (B, D, and F) analyzed by in situ hybridization is shown in purple and β-gal is
rsal views with posterior to the top. (G) FoxB1 and ΔBMPR cooperatively expand the
iment was repeated more than twice and gave similar results. (H) FoxB1 and ΔBMPR
s are not presented.
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members of the Fox family have been found to interact with Smads
(Blount et al., 2009; Chen et al., 1997; Labbé et al., 1998; Liu et al.,
1997; Rodriguez et al., 2001; Seoane et al., 2004; Wang et al., 2005;
Zhou et al., 1998), and it is also known that among BMP signal-Fig. 3. FoxB1 cooperates with FGF signaling to promote neural development. (A–I) FoxB1 coo
er with β-gal mRNA, GR-FoxB1 (250 pg) and eFGF mRNA (0.25 pg) were injected unilaterall
The expression of neural markers Sox2 (neural plate; A, D and G), En2 (midbrain–hindbrain
ization is shown in purple and β-gal is stained in red. The embryos injected with both GR-F
expression (arrowheads in D, E and F, respectively), compared to embryos injected with eith
All panels show dorsal views with posterior to the top, except for En2 (B, E, and H) where t
shown in (A)–(I). FoxB1 and eFGF cooperatively expand expression domains of Sox2 (J), En
similar results.speciﬁc R-Smads, Smad8 is abundantly expressed during early Xeno-
pus embryogenesis (Miyanaga et al., 2002). Therefore, we ﬁrst asked
whether FoxB1 physically associates with Smad8 using co-immuno-
precipitation (co-IP) assays with FoxB1 and Smad8 tagged with Myc
and FLAG epitopes, respectively. We found that FoxB1 can interactperates with eFGF to promote neural induction and posterior neural formation. Togeth-
y into both dorsal and ventral animal blastomeres of 8-cell stage embryos as indicated.
boundary; B, E, and H), and HoxB9 (spinal cord; C, F and I) analyzed by in situ hybrid-
oxB1 and eFGF mRNA displayed a more pronounced expansion of Sox2, En2 and HoxB9
er mRNA alone (A–C and G–I). The injected side of the embryo is indicated by brackets.
he anterior (front) view with dorsal to the top is shown. (J–L) Summary of phenotypes
2 (K) and HoxB9 (L) genes. Each experiment was repeated more than twice and gave
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directly modulate the levels of phosphorylation of Smads. To deter-
mine whether the C-terminal phosphorylation status of Smad8 affects
its interaction with FoxB1, we performed co-IP experiments using
non-phosphorylatable and phospho-mimicking mutant forms of
Smad8 (Smad8AAVA and Smad8SEVE, respectively). As shown in
Fig. 1E, FoxB1 binds Smad8AAVA better than Smad8SEVE or wild-
type Smad8 (lanes 5–7), suggesting that it preferentially interacts
with unphosphorylated Smad8 in vivo.
Immunocytochemical analysis showed that FoxB1 is localized to
the nuclei of HeLa (Fig. 1F) and Xenopus ectodermal cells (data not
shown). Therefore, we hypothesized that FoxB1 facilitates nuclear re-
tention of unphosphorylated Smad8, thereby disturbing recycling of
the latter into the cytoplasm and/or its activation by the type I recep-
tor. To test this hypothesis, we analyzed the localization of FLAG-
Smad8AAVA in Xenopus ectodermal cells in the presence or absence
of Myc-GR-FoxB1 using immunoﬂuorescence microscopy (Figs. 1G
and H). FLAG-Smad8AAVA proteins were present both in the nucleus
and cytoplasm as well as near the plasma membrane, as previouslyFig. 4. FoxB1 cooperates with BMP inhibition and FGF signaling to neuralize and poster-
iorize the ectodermal explants. GR-FoxB1 (250 pg and 500 pg), ΔBMPR (270 pg) and
eFGF mRNA (0.1 pg) were injected separately or in combination into the animal pole
of 8-cell stage embryos as indicated. Ectodermal explants were isolated at the blastula
stage, treated with DEX to activate FoxB1 and cultured until late neurula stage (st.
21). The expression of marker genes was determined by semi-quantitative RT-PCR. In
combination with ΔBMPR, FoxB1 increased the level of expression of the neural plate
markers Sox2 and SIP1 and reduced epidermal keratin gene expression (compare lanes
4 and 5 with 13 and 14). Together with eFGF, FoxB1 upregulated the expression of the
spinal cord marker HoxB9 compared to GR-FoxB1 mRNA alone (compare lanes 4 and 5
with 7 and 8). Moreover, when all three components were expressed together (lanes
10 and 11), both neural plate and posterior neural makers were strongly induced.described for Smad2 without ligand stimulation (Batut et al., 2007).
In contrast, in the presence of Myc-GR-FoxB1, the number of cells
showing predominantly nuclear staining for FLAG-Smad8AAVA was
signiﬁcantly increased. Together, these results suggest that FoxB1
promotes neural induction and suppresses epidermal differentiation
by inhibiting BMP signaling through a mechanism involving, at least
in part, nuclear sequestration of unphosphorylated Smad8, which re-
duces phosphorylation of Smad8 during embryogenesis.
FoxB1 cooperates with inhibition of BMP signaling and with FGF signal-
ing to promote neural development
The promotion of neural development by FoxB1 in ectodermal ex-
plants prompted us to examine whether FoxB1 affects the formation
of the neural plate. We injected mRNA encoding inducible GR-FoxB1
together with β-galactosidase mRNA as a lineage tracer unilaterally
into both dorsal and ventral animal blastomeres of 8-cell-stage em-
bryos. We then activated GR-FoxB1 after the blastula stage by treating
the embryos with DEX (Figs. 2 and 3). To evaluate the effects of the
injected mRNA on the neural plate, we compared the width of the ex-
pression domain of the neural plate marker Sox2 on the injected and
uninjected sides. We observed that overexpression of GR-FoxB1
slightly expanded the expression domain of Sox2 (18% (n=33) in
Figs. 2A and G; 44% (n=36) in Figs. 3A and J). However, when com-
bined with BMP inhibition, by means of the expression of a dominant
negative BMP receptor (ΔBMPR), or with FGF signals (which have
been shown to promote neural induction and posteriorization) (Cox
and Hemmati-Brivanlou, 1995; Kengaku and Okamoto, 1995; Lamb
and Harland, 1995; Pownall et al., 1996; Sasai et al., 1995; Suzuki et
al., 1995; Xu et al., 1995), FoxB1 efﬁciently expanded the neural
plate. Together with small amounts of ΔBMPR mRNA, which only
weakly promote neural induction (Figs. 2E and G), FoxB1 strongly ex-
panded the area of the neural plate that was positive for Sox2 expres-
sion (38% of embryos (n=29) when moderate and strong
phenotypes were combined; Figs. 2C and G). This occurred at the ex-
pense of the epidermal marker epidermal keratin (67%, n=15;
Fig. 2D). A similar result was also obtained for the expression of
NCAM in embryos coinjected with GR-FoxB1 and ΔBMPR mRNAs
(data not shown). In the presence of eFGF, a Xenopus homolog of
FGF4, FoxB1 markedly expanded the expression of Sox2 (42% of em-
bryos (n=33) when moderate and strong phenotypes were com-
bined; Figs. 3D and J), while eFGF alone had a relatively weak effect
(Figs. 3G and J). Interestingly, in addition to Sox2, FoxB1 cooperated
with eFGF to expand the expression domain of the posterior neural
markers En2 and HoxB9 that mark the mid-hindbrain boundary and
the spinal cord, respectively. Embryos injected with both GR-FoxB1
and eFGF mRNA displayed a more pronounced expansion of En2 and
HoxB9 expression (33% (n=54) and 47% (n=30), respectively,
when moderate and strong phenotypes were combined; Figs. 3E, F,
K and L), compared to embryos injected with either mRNA alone
(Figs. 3B, H, C and I). A similar result was obtained with FGFR1-
K562E, a cell-autonomous activator of the FGF signal, which itself
showed a relatively stronger effect than eFGF on the expression of
En2 and HoxB9 (Supplemental Fig. 4). The differences in the degree
of phenotypes among eFGF and FGFR1-K562E might be due to a dif-
ference in the diffusion of the proteins. In contrast, the coinjection
of GR-FoxB1 and ΔBMPR mRNAs displayed no signiﬁcant cooperative
effect on the expansion of En2 expression (Fig. 2H). This may have
been due to anteriorizing effects of ΔBMPR which is commonly ob-
served for BMP antagonism (Hemmati-Brivanlou et al., 1994; Lamb
et al., 1993; Sasai et al., 1995).
In order to precisely determine the cooperative action of FoxB1
with BMP inhibition and with FGF signaling in the DV and AP pattern-
ing of the ectoderm, we expressed these factors in ectodermal ex-
plants separately or in combination (Fig. 4). In combination with
ΔBMPR (270 pg), which alone exerts only a minimal effect on Sox2
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of Sox2 and SIP1, accompanied by reduction of epidermal keratin gene
expression (compare lanes 3–5 and 12–14). Moreover, in this situa-
tion, FoxB1 induced the mid-hindbrain boundary marker En2 and
hindbrain marker Krox20 (lanes 13 and 14), indicating that in combi-
nation with BMP inhibition, FoxB1 promotes not only neural induc-
tion, but also the formation of posterior neural tissue. The promotion
of En2 expression by a combination of FoxB1 and ΔBMPR in ectoder-
mal explants, but not in whole embryos (Fig. 2H), might have resulted
from the absence of anteriorizing factors such as Dickkopf (Dkk) and
Cerberus in the explants. In combination with eFGF, FoxB1 induced
the expression of the spinal cord marker HoxB9 much more strongly
than GR-FoxB1 mRNA alone, which resulted in very faint expression
of HoxB9 (compare lanes 4 and 5 with 7 and 8). This suggests that
FoxB1 could function together with FGF signaling to form posterior
neural tissue. In the case of all three components together (lanes 10
and 11), the expression of both neural plate and posterior markers
was markedly increased, with a difference in the type of posterior
markers expressed which shifted anteriorly from HoxB9 to En2 and
Krox20 (compare lanes 7 and 8 with 10 and 11). The shift is likely to
be due to the anteriorizing effects of BMP inhibition caused by
ΔBMPR, as indicated by induction of the fore- and mid-brain marker
Otx2 and the cement gland marker XAG1 (lanes 9–14). Moreover, in
agreement with the upregulation of posterior markers, the expression
of Otx2 and XAG1was downregulated by FoxB1 (lanes 9–11), indicat-
ing that FoxB1 can posteriorize neural tissue generated by ΔBMPR.
Taken together, these data clearly demonstrate that FoxB1 regulates
not only the DV patterning, but also the AP patterning of the ectoderm
in collaboration with BMP inhibition and with FGF signaling.
FoxB1 is required for the formation of posterior neural tissue
In order to analyze the role of endogenous FoxB1 in the DV and AP
patterning of Xenopus embryos, we downregulated FoxB1 during em-
bryogenesis by using an antisense morpholino oligonucleotide
designed against FoxB1 (FoxB1 MO). We conﬁrmed that FoxB1 MO,
but not its 6-base-mismatched control MO (6mis FoxB1 MO), efﬁ-
ciently reduced the translation of FoxB1 mRNA in an in vitro transla-
tion assay (Supplemental Fig. 5). Injection of FoxB1 MO into the
animal pole of 1-cell embryos resulted in grossly normal embryos
with a moderately bent axis at tailbud stages (65%, n=37; Supple-
mental Fig. 6). We next analyzed neurula stage embryos injected
with FoxB1 MO into one blastomere at the 2-cell stage by whole-
mount in situ hybridization (Fig. 5). We found that the expression of
the spinal cord marker HoxB9 on the injected side was reduced and
the anterior limits of HoxB9 expression shifted caudally with respect
to the uninjected side of the embryo (56%, n=205; Figs. 5J, J′ and
Y). A similar reduction was also observed for HoxC6 expressed in
the spinal cord (48%, n=46; Fig. 5L). In contrast, the area of expres-
sion of both the fore- and mid-brain marker Otx2 (47%, n=59) and
the retinal marker Rx2A (51%, n=37) was expanded on the FoxB1
MO-injected side (Figs. 5B and D). Similar results were also obtained
for a second MO (FoxB1 MO2) targeting another allele of Xenopus
FoxB1 (Supplemental Fig. 5) found in the EST database (44%
(n=32) for HoxB9 reduction and 43% (n=14) for Otx2 expansion;
data not shown). A third MO (FoxB1 MO3) designed upstream of
FoxB1 MO2 also reduced HoxB9 expression (68%, n=62) and ex-
panded Otx2 (43%, n=14) (data not shown). Because coinjection of
FoxB1 MOwith either FoxB1 MO2 or MO3 showed only a minor addi-
tive effect (61% (n=31) and 51% (n=57) of HoxB9 reduction for the
combinations of FoxB1 MO/MO2 and MO/MO3, respectively; data not
shown), we used FoxB1 MO for further analyses. In addition, coinjec-
tion of FoxB1 MO with an MO designed against FoxB2 increased
HoxB9 reduction only slightly (Supplemental Fig. 7), indicating that
there is limited functional redundancy between FoxB1 and FoxB2,
which is expressed in a small part of the neural plate and for a shortperiod of time during development (Pohl et al., 2002). The 6mis
FoxB1MO showed greatly reduced effects (15% (n=61) on HoxB9 re-
duction and 15% (n=13) for Otx2 expansion; Fig. 5Y) and the Gene-
Tools Control MO had no signiﬁcant effect at all (7% (n=114) for
HoxB9 reduction, 4% (n=46) and 0% (n=34) for Otx2 and Rx2A ex-
pansion, respectively; Figs. 5A, C, I, I′ and Y). In addition, the expres-
sion of the paraxial mesodermal marker MyoD was not signiﬁcantly
affected by FoxB1 MO (n=30; Fig. 5N).
The reduction of HoxB9 and HoxC6 concomitant with expansion of
Otx2 and Rx2A in FoxB1morphants indicates an overall anteriorization
of the neural plate. In fact, the mid- and hind-brain boundary marker
En2 and the hindbrain marker Krox20 were also expanded in FoxB1
morphants (44% (n=78) and 40% (n=48), respectively; Figs. 5F
and H). Consistent with these results, previous studies have reported
that FoxB1, HoxB9 and HoxC6 are expressed in the spinal cord and
that FoxB1 is in part coexpressed with En2 and Krox20 (Bardine et al.,
2009; Gamse and Sive, 2001; Godsave et al., 1994; Pohl et al., 2002).
In addition, FoxB1 expression partially overlapped with that of Otx2
in the midbrain and posterior part of the presumptive forebrain
where the retinal marker Rx genes are also detected (Mathers et al.,
1997; Zuber et al., 2003). Thus, it is reasonable that the loss of FoxB1
affects the expression of these marker genes. In order to conﬁrm pre-
cisely the change in the AP patterning of the neural plate, we isolated
the dorsal ectodermal explants from FoxB1morphants at late gastrula
stages and determined the expression levels of marker genes (Figs. 5O
and P). In agreement with the results of in situ hybridization analysis,
inhibition of FoxB1 function indeed resulted in anteriorization of the
ectoderm. In addition, the reduction of HoxB9 and HoxC6 expression
was observed with no apparent reduction of Sox2 expression, indicat-
ing that the posterior neural defects are not simply due to loss of the
neural (dorsal) fate of the ectoderm where FoxB1 is expressed. The
upregulation of En2 and Krox20 expression in FoxB1 morphants con-
tradicts the notion that FoxB1 promotes posteriorization in the pres-
ence of eFGF (Figs. 3 and 4). However, this could be explained by the
possibility that FoxB1 regulates AP positional value globally through
intermediate factors, rather than acting directly on the expression of
the posterior marker genes. In this case, the reduction of spinal cord
marker expression by FoxB1 inhibition could result in upregulation
of the expression of En2 and Krox20 that is located anterior to the spi-
nal cord.
The speciﬁcity of the effects mediated by FoxB1 MO was tested by
coinjection of FoxB1 MO with Nmut-FoxB1 RNA, which has mutations
in the target site of FoxB1 MO (Figs. 5R–S′). The degree of recovery in
the HoxB9 expression domains was scored according to the direction
of change along the AP or DV axis, which corresponds to the medio-
lateral axis at this stage (Fig. 5T), and was categorized into three
types: reduced along the AP axis (AP reduced), reduced along the
AP axis with expansion along the DV axis (AP reduced/DV expanded),
and expansion along the DV axis (DV expanded) (Fig. 5Y). Nmut-
FoxB1 partially but signiﬁcantly rescued the reduction of HoxB9 ex-
pression by FoxB1 MO in a dose-dependent manner (Fig. 5Y). While
a small but substantial number of embryos injected with Nmut-
FoxB1 mRNA (1000 pg) retained the reduced expression of HoxB9 in
the AP direction, a large proportion of these embryos showed expan-
sion of HoxB9 expression ventrally (laterally) and was categorized
into the AP reduced/DV expanded class (Figs. 5S and S′). This partial
rescue by Nmut-FoxB1 might be due to a distribution of exogenous
FoxB1 that does not match up with the localized expression pattern
of the endogenous FoxB1.
Involvement of Wnt and FGF signals in the regulation of neural
patterning by FoxB1
It has been demonstrated that Wnt and FGF signals promote,
while RA suppresses, the formation of the posterior spinal cord
which expresses posterior Hox genes such as HoxB9 and HoxC9
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1999; Lamb and Harland, 1995; Liu et al., 2001; McGrew et al.,
1997; Nordström et al., 2006; Pownall et al., 1996; Ribisi et al.,
2000), and that the expression of FoxB1 is induced by Wnt and FGF
signals, but not by RA (Gamse and Sive, 2001). These observations
led us to determine the relationship between Wnt, FGF and FoxB1in the formation of the spinal cord. We overexpressed either XWnt-
8 or eFGF in FoxB1 morphant embryos and assessed their ability to
rescue the reduction of the spinal cord marker HoxB9. As shown in
Figs. 5U, U′ and Y, XWnt-8 partially rescued the expression of HoxB9
in FoxB1morphant in the AP direction. The efﬁcacy of the XWnt-8 res-
cue was comparable to Nmut-FoxB1. Conversely, eFGF was unable to
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Use of too small an amount of eFGFmRNA was not the reason for the
inefﬁcient rescue of the FoxB1 MO phenotype along the AP axis, be-
cause the same amount of eFGFmRNA (1 pg) coinjected with Control
MO expanded HoxB9 expression effectively along the DV axis
(Figs. 5X, X′ and Y). It has been shown that Wnts act directly in the
establishment of posterior neural character and that FGFs act in a per-
missive manner during chick embryogenesis (Nordström et al., 2002).
In fact, coexpression of XWnt-8 and eFGF rescued HoxB9 expression in
the AP direction slightly better than each factor alone (Figs. 5W, W′
and Y). In addition, instead of these ligands, the use of cell-autono-
mous activators of Wnt and FGF signals (TVGR and FGFR1-K562E, re-
spectively) also showed a similar effect with less efﬁciency, possibly
due to inhomogeneous distribution of proteins (Supplemental Fig.
8). These results indicate that the function of FoxB1 in the formation
of posterior neural tissue can be, at least in part, replaced by activa-
tion of the Wnt and FGF pathways. Taken together, these data suggest
that FoxB1 functions together withWnt and FGF signaling to promote
posterior neural development, where Wnts primarily specify AP posi-
tional identity and FGFs are likely to play a supportive role.
The rescue of FoxB1 morphants by XWnt-8 as well as by a combi-
nation of XWnt-8 and eFGF indicates that these factors could mediate
the role of FoxB1 in embryonic AP patterning. In accordance with the
posteriorization function of FoxB1, as indicated by enhanced expres-
sion of posterior neural markers (Figs. 3 and 4), we observed that
its overexpression resulted in the suppression of anterior structures
such as the cement glands and eyes by tailbud stages (Figs. 6B and
B′). At late neurula stages, most embryos (88%, n=41) injected
with GR-FoxB1 mRNA showed defects in the cement glands and
some of them had no cement glands at all (Figs. 6D and F). In situ hy-
bridization for the retinal marker Rx2A also showed that the eye
structures were reduced or even missing in the GR-FoxB1 mRNA
injected-embryos when evaluated at the tailbud stages (56% of em-
bryos (n=41) contained little or no Rx2A-positive retina on either
the left or right side; Figs. 6H and J). We then addressed whether in-
hibition of the Wnt pathway reversed these defects caused by FoxB1
overexpression. When FoxB1 mRNA was injected together with Dkk
mRNA, which inhibits Wnt signaling (Glinka et al., 1998), into animal
blastomeres of 4-cell stage embryos, the reduction of the cement
glands was rescued completely (n=28; Figs. 6E and F). In addition,
the fraction of embryos with little or no Rx2A expression was substan-
tially decreased to 26% (n=27; Figs. 6I and J). Dkk has been shown to
inhibit Wnt signaling by interfering with the formation of active
Wnt/Frizzled ligand-receptor complexes in the extracellular space
(Baﬁco et al., 2001; Mao et al., 2002; Semënov et al., 2001). Therefore,
we asked whether FoxB1 regulated the expression of Wnt ligands
during embryogenesis. We assessed the expression of three Wnt li-
gands (XWnt-8, XWnt-3A and XWnt-1) present in the gastrula andFig. 5. FoxB1 is required for the formation of posterior neural tissue and the suppression
columns) or FoxB1 MO (34 ng, right columns) were injected unilaterally into the 2-cell stag
D), En2 (mid-hindbrain boundary; E and F), Krox20 (hindbrain; G and H), HoxB9 (spinal co
analyzed by in situ hybridization is shown in purple and β-gal is stained in red. In embryos
to rhombomere 3) on the injected side was expanded (arrowheads; B, D, F and H) and th
(the horizontal lines mark approximate anterior limits of the expression). The expression
the embryo is indicated by brackets. A–H: anterior (front) view with dorsal to the top; I–N: d
genes in dorsal ectodermal explants. Embryos were injected with Control or FoxB1 MO (34 n
todermal explants were isolated from a presumptive posterior neural plate region indicted
21) and analyzed by QPCR (P). The relative level of expression (arbitrary units) normalized
twice and gave similar results. (Q-X′) FoxB1 acts together with Wnt and FGF signaling to
embryos were injected unilaterally with a mixture of MO and mRNA or DNA as indicated: F
XWnt-8 DNA (500 pg; U and U′), eFGF mRNA (1 pg; V and V′) or both XWnt-8 DNA (500 pg)
X′). Expression of the HoxB9 gene analyzed by in situ hybridization is shown in purple and
HoxB9 expression by FoxB1 MO (horizontal lines, compare Q′with R′ and S′). Moreover, in e
partially (horizontal lines, U′) and coexpression of XWnt-8 and eFGF showed slightly better
expression of HoxB9 in the anterior–posterior (AP) direction. In some embryos, HoxB9 exp
The injected side of the embryo is indicated by brackets. All panels show dorsal views with
shown in (I)–(J′) and (Q)–(X′). The degree of recovery in the HoxB9 expression domains
(T), and categorized into three types: reduced along the AP axis (AP reduced), reduced a
expansion along the DV axis (DV expanded). Numbers of embryos per experimental grouneurula (Christian et al., 1991; Elkouby et al., 2010; Hong et al.,
2008; Park and Saint-Jeannet, 2008; Wolda et al., 1993). Because
FGFs could function together with Wnts in posterior neural develop-
ment, we also examined the expression of three FGF ligands (eFGF,
FGF3 and FGF8) (Christen and Slack, 1997; Hong et al., 2008; Isaacs
et al., 1995; Lombardo et al., 1998; Park and Saint-Jeannet, 2008).
As shown in Fig. 6K, QPCR analysis of ectodermal explants expressing
FoxB1 revealed that FoxB1 signiﬁcantly upregulates the expression of
XWnt-8, eFGF, FGF3 and FGF8, but not XWnt-3A or XWnt-1 (data not
shown), at late gastrula stages (st. 12.5). Similar results were also
obtained at neurula stages (st. 15/16). This indicates that FoxB1 regu-
lates the expression of at least some members of the Wnt and FGF
families. We next asked whether these ﬁndings in ectodermal ex-
plants also hold true in whole embryos. Using whole-mount in situ
hybridization, we found that overexpression of FoxB1 resulted in a
moderate expansion of XWnt-8 as well as FGF ligand expression do-
mains (Figs. 6L–O′). It has been shown that XWnt-8 is expressed in
the dorso-lateral region of the ectoderm and mesoderm, excluding
the anterior part of the embryo, and in the ventro-lateral region of
the blastopore (Supplemental Fig. 9). All the FGF ligands are com-
monly expressed around the blastopore in addition to gene-speciﬁc
expression domains in the anterior regions. Of note, FoxB1 along
with Oct-25 is also expressed dorsally in both the ectoderm and me-
soderm layers of the blastopore where XWnt-8 and FGF transcripts
are also found. Upon overexpression of FoxB1, the expression of
XWnt-8 is expanded laterally and ventrally around the posterior
part of the embryo (88%, n=16; Figs. 6L–L″). The expression of FGF
ligands was also found to be expanded (67%, n=12 for eFGF; 94%,
n=18 for FGF3; 77%, n=13 for FGF8; Figs. 6M–O′). Therefore, these
results suggest the possibility that FoxB1 suppresses anterior devel-
opment via activation of the Wnt and FGF pathways.
To determine whether FoxB1 requires the function ofWnt and FGF
ligands to suppress anterior structures, we coinjected GR-FoxB1
mRNA together with either XWnt-8 MO, eFGF MO or FGF3 MO, and
examined the formation of the cement glands at neurula stages
(Figs. 6P–U and V). While the majority of embryos coinjected with
GR-FoxB1 mRNA and Control MO had small or no cement glands
(93%, n=30; Fig. 6Q), the frequency of defects was signiﬁcantly re-
duced in embryos coinjected with GR-FoxB1 mRNA and XWnt-8 MO
(Figs. 6R and V). This indicates that FoxB1 requires endogenous
XWnt-8 function to suppress anterior development. In contrast to
XWnt-8 MO, eFGF MO had a weaker effect on the FoxB1-dependent
suppression of cement gland formation (Fig. 6S). FGF3 MO had only
a weak effect (Fig. 6T). In addition, neither the combination of
XWnt-8 MO/eFGF MO (66%, n=29; data not shown) nor all three
MOs (Triple Mix; Fig. 6U) was as efﬁcient as XWnt-8 MO alone for
rescuing cement gland formation. Moreover, in situ hybridization for
the retinal marker Rx2A also conﬁrmed the conclusion that FoxB1of anterior tissue. (A–N) Together with β-gal mRNA, either Control MO (34 ng, left
e embryos. The expression of Otx2 (fore- and mid-brain; A and B), Rx2A (retina; C and
rd; I-J′), HoxC6 (spinal cord; K and L), and MyoD (paraxial mesoderm; M and N) genes
injected with FoxB1 MO, the expression of Otx2, Rx2A, En2 and Krox20 (corresponding
e expression of HoxB9 (J and J′) and HoxC6 (L) was decreased and shifted posteriorly
pattern of MyoD was not signiﬁcantly affected by FoxB1 MO (N). The injected side of
orsal view with posterior to the top. (O and P) Expression of anterior–posterior marker
g/blastomere) at 2-cell stage and cultured until late gastrula stage (st. 12.5). Dorsal ec-
by a black square (O). The isolated explants were cultured until the neurula stage (st.
to ODC expression is shown for each gene. Each experiment was repeated more than
promote posterior neural development. Together with β-gal mRNA, the 2-cell stage
oxB1 MO alone (34 ng; Q and Q′); FoxB1 MO with Nmut-FoxB1 mRNA (1000 pg; R–S′),
and eFGF mRNA (1 pg; W and W′); Control MO (34 ng) with eFGF mRNA (1 pg; X and
β-gal is stained in red. Nmut-FoxB1 partially but signiﬁcantly rescued the reduction of
mbryos injected with FoxB1 MO and XWnt-8 DNA, the expression of HoxB9was rescued
rescuing activities (W and W′). eFGF alone (1 pg; V and V′) was not able to rescue the
ression was even expanded in the dorsal-ventral (DV) direction (arrowheads, S–X).
posterior to the top. (Y) Summary of phenotypes obtained from several experiments
was scored according to the direction of change along the AP or DV axis as shown in
long the AP axis with expansion along the DV axis (AP reduced/DV expanded), and
p are indicated above the bars.
22 K. Takebayashi-Suzuki et al. / Developmental Biology 360 (2011) 11–29requires the function of XWnt-8 and eFGF ligands for the suppression
of anterior structures (Fig. 6W). When XWnt-8 MO was coinjected
with GR-FoxB1 mRNA, the suppression of Rx2A expression (“little or
no” phenotype) recovered from 77% (n=30) to 47% (n=32). eFGFMO also rescued Rx2A expression, although considerably less mark-
edly than XWnt-8 MO. In addition, in most embryos injected with ei-
ther FGF3 MO or a mixture of all these MOs (Triple Mix), suppression
of Rx2A expression was maintained. Lastly, we examined whether
Fig. 6 (continued).
23K. Takebayashi-Suzuki et al. / Developmental Biology 360 (2011) 11–29FoxB1 is required for the expression ofWnt and FGF ligand genes. For
this purpose, we quantiﬁed the expression of these genes in dorsal ec-
todermal explants where FoxB1 regulates AP patterning. We found
that FoxB1 MO efﬁciently reduced the expression of XWnt-8, whereas
the expression of eFGF and FGF8, but not FGF3, was moderately re-
duced, indicating that the expression of Wnt-8 and some FGF genes
are under the control of FoxB1 (Supplemental Fig. 10). These results
suggest that FoxB1 suppresses anterior development via activation
of the Wnt and FGF pathways, which is likely to involve upregulation
of at least XWnt-8 and eFGF expression.FoxB1 collaborates with Oct-25 in the process of neural induction
Gain-of-function studies with FoxB1 indicated that it promotes
neuralization of the ectoderm and posteriorization of neural tissue,
thereby regulating both DV and AP patterning during embryogenesis.
As expected, downregulation of endogenous FoxB1 led to defects in
the AP patterning of embryos (Fig. 5). However, there was no signif-
icant reduction in the expression of the neural plate markers Sox2
(8% of embryos with suppression, n=37; Fig. 7A) or NCAM (data
not shown), nor any expansion of epidermal keratin expression (6%
24 K. Takebayashi-Suzuki et al. / Developmental Biology 360 (2011) 11–29of embryos with expansion, n=36; Fig. 7B). We reasoned that the ap-
parent lack of DV patterning defects in FoxB1morphants could be due
to compensation by other neural-inducing factors operating in paral-
lel with FoxB1. A good candidate for such a factor is Oct-25, as it is
able to activate transcription of FoxB1 and is essential for neuraliza-
tion of the ectoderm (Takebayashi-Suzuki et al., 2007). In order to es-
tablish a functional relationship between FoxB1 and Oct-25, we
tested whether downregulation of FoxB1 exacerbates the neural de-
fects observed in Oct-25 morphants. As we previously reported, inhi-
bition of Oct-25 function alone caused a moderate reduction of Sox2
(49%, n=57; Fig. 7E) and upregulation of epidermal keratin (63%,
n=40; Fig. 7F). Interestingly, however, inhibition of both FoxB1 and
Oct-25 function resulted in a marked reduction in the expression of
Sox2 in a large proportion of embryos (78%, n=67; Fig. 7C), and
also caused the expression of epidermal keratin to extend into neural
plate territory (80%, n=41; Fig. 7D). The speciﬁcity of the effects of
FoxB1 MO was conﬁrmed by the rescue of Sox2 expression to the
levels observed for Oct-25 MO alone, when Nmut-FoxB1 mRNA was
coinjected with the mixture of MOs (40% of embryos (n=30) with
suppression; Fig. 7G). Moreover, inhibition of BMP signaling by
ΔBMPR also rescued the severe defects in Sox2 expression (42% of
embryos (n=24) with suppression; Fig. 7H). This indicates that the
severe reduction of Sox2 expression is likely to result from an increase
in BMP signaling upon simultaneous loss of Oct-25 and FoxB1. These
results further suggest that FoxB1 could function in parallel with Oct-
25 in both acquisition of neural fate and inhibition of epidermal
differentiation, and that Oct-25 can compensate, at least in part,
for the loss of FoxB1 in the neural plate and can maintain neural
fate of the ectoderm. Thus, the loss of Oct-25 function now reveals
an important role for FoxB1 in the regulation of DV patterning of
the ectoderm.
In order to conﬁrm a requirement for FoxB1 in DV patterning in
cooperationwithOct-25,we next determinedwhether FoxB1 is required
for neuralization of the ectoderm by Oct-25 overexpression.We injected
GR-Oct-25mRNA together with FoxB1MO into animal poles at the 4-cell
stage and assessed the expression of Sox2 by QPCR (Fig. 7I). At both early
and late neurula stages, FoxB1 MO partially suppressed the induction of
Sox2 expression by Oct-25. Moreover, this reduction in Sox2 expression
was efﬁciently rescued by expression of Nmut-FoxB1 mRNA, indicating
speciﬁc effects of FoxB1 MO on Sox2 expression in ectodermal explants.
These results suggest that FoxB1 is in part required for neuralization
of the ectoderm by Oct-25. In summary, FoxB1 regulates not only
the AP patterning, but also the DV patterning of the ectoderm during
early embryogenesis. Given that FoxB1 is a downstream factor of
Oct-25, the results described above indicate that FoxB1 and Oct-25
form a regulatory network essential for neural induction processes
(Fig. 7J and see Discussion).Fig. 6. FoxB1 suppresses anterior development via the expression ofWnt and FGF ligands. (A–B′)
glands and eyes. GR-FoxB1mRNA (250 pg; B and B′) were injected into four animal blastomeres o
showanterior to the left. (C–E) Suppressionof the cement glands in embryos overexpressing FoxB1
GR-FoxB1mRNA(500 pg)was injectedwith (E) orwithout (D)DkkmRNA(50 pg) into four anima
top. (F) Summary of phenotypes observed in the experiment shown in (C)–(E). (G–I) Inhibition o
caused by FoxB1 overexpression. Neurula stage embryos were injectedwith GR-FoxB1mRNA (500
bryos. An uninjected control embryo is shown in (G). The expression of Rx2A gene analyzed by in s
top. (J) Summary of phenotypes shown in (G)–(I). (K) FoxB1 promotes the expression ofWnt an
animal pole of 4- to 8-cell stage. Ectodermal explants were isolated at the blastula stage, treated
15/16). The relative level of expression of each gene (normalized to ODC expression) was quanti
embryos. Together with β-gal mRNA, GR-FoxB1 mRNA (500 pg) was injected unilaterally into bo
8 (L–L″; st. 15/16), eFGF (M; st. 15/16), FGF3 (N andN′; st. 12.5) or FGF8 (O andO′; st. 12.5) analyze
of FoxB1, the expression of XWnt-8 expands laterally and ventrally around the posterior part of the
(arrowheads, M–O′). The injected side of the embryo is indicated by brackets. L, M, N, and O: pos
anterior to the top; L′: lateral view of (L) with anterior to the left; L″: lateral view of (L) with anter
of anterior structures. GR-FoxB1mRNA (500 pg) in combinationwith the indicatedMOs (40 ng to
sion of the cement glands in FoxB1-overexpressing embryos was rescued efﬁciently by XWnt-8 M
FGF3MO showed a limited effect. (V) Summary of phenotypes shown in (P)–(U). (W) Summary
expression caused by FoxB1overexpression.While neither FGF3MOnor a combination of all three
(T) indicate the position of the cement gland.Discussion
Here we explored a new aspect of forkhead transcription factor
FoxB1 function during vertebrate embryogenesis. We report three
main ﬁndings. First, FoxB1 suppresses BMP-dependent epidermis for-
mation and promotes neural induction, thereby regulating the DV
patterning of the ectoderm. Second, FoxB1 is required for the forma-
tion of posterior neural tissue and suppresses anterior development
by a mechanism involving the FGF and Wnt pathways. Third, FoxB1
functions both downstream of and in concert with the BMP inhibitory
factor Oct-25, forming a regulatory network essential for induction
and/or maintenance of neural tissue. These ﬁndings support the no-
tion that FoxB1 regulates the establishment of the DV and AP axes
of the ectoderm, which requires integrative interactions between
BMP, FGF and Wnt signals. Our ﬁndings add FoxB1 to a set of regula-
tors ensuring the establishment of the body plan during early em-
bryogenesis by coordinating the formation of the DV and AP axes,
which are the two distinct but intimately linked patterning events.
FoxB1 negatively regulates BMP signaling and controls the dorsal–ventral
patterning of the ectoderm
Our results showed that FoxB1 suppresses BMP-mediated epider-
mal differentiation and promotes neural induction in the ectoderm
(Fig. 1C). It has been shown that BMP genes are expressed both ma-
ternally and zygotically (Hemmati-Brivanlou and Thomsen, 1995;
Nishimatsu et al., 1992), and that C-terminal phosphorylation of
Smad1/5/8 is detected as early as the blastula stages and is main-
tained throughout neurulation (Faure et al., 2000; Kurata et al.,
2000; Schohl and Fagotto, 2002). Hartley et al. also reported that mis-
expression of BMP4 during neurula stages suppresses neural fate of
the ectoderm and that BMP genes are expressed in mesodermal tis-
sues underlying the neural plate (Hartley et al., 2001). In addition, it
has been reported that BMP inhibition during gastrulation is impor-
tant for neural induction (Gestri et al., 2005; Khokha et al., 2005;
Marchal et al., 2009; Wills et al., 2010). Thus, induction and mainte-
nance of neural tissue requires continuous inhibition of ongoing BMP
signals arising from BMP ligands that are not only maternally inherited,
but also zygotically expressed within the ectoderm and in tissues sur-
rounding the neuroectoderm. It has been reported that the Xenopus
FoxB1 is expressed in the dorsal ectoderm of the early gastrula (Gamse
and Sive, 2001) and maintained in the neural plate during early neurula
stages.We found that FoxB1 is not only capable of inducing neural tissue,
but also reduces the levels of pSmad1/5/8 in ectodermal cells during
gastrula stages (Figs. 1B–D). Moreover, we also found that FoxB1
associates with Smad8, which is expressed throughout embryogenesis
(Fig. 1E), and sequesters Smad8 in the nucleus during gastrulationOverexpression of FoxB1 results in the suppression of anterior structures such as the cement
f 4- to 8-cell stage embryos. Injected embryoswere cultured until the tailbud stage. All panels
was rescuedby the inhibitionofWnt signaling. Uninjected control embryos are shown in (C).
l blastomeres of 4-cell stage embryos. All panels showanterior (front) viewswithdorsal to the
f theWnt pathway partially rescues defects in the expression of the retinal marker Rx2A gene
pg; H) alone or together withDkkmRNA (50 pg; I) into the animal poles of 4-cell stage em-
itu hybridization is shown in purple. All panels show anterior (front) viewswith dorsal to the
d FGF ligand genes in ectodermal explants. GR-FoxB1mRNA (500 pg) was injected into the
with DEX to activate FoxB1 and cultured until gastrula (st. 12.5) or early neurula stage (st.
ﬁed by QPCR. (L–O′) FoxB1 expands the expression domain ofWnt and FGF ligand genes in
th dorsal and ventral animal blastomeres of 8-cell stage embryos. The expression of XWnt-
d by in situ hybridization is shown in purple and β-gal is stained in red. Upon overexpression
embryo (arrowheads, L and L″). The expression of FGF ligandswas also found to be expanded
terior views with dorsal to the top; N′ and O′: dorsal view of (N) and (O), respectively, with
ior to the right. (P–U) FoxB1 requires the function of XWnt-8 and FGF ligands for suppression
tal per embryo) were injected into four animal blastomeres of 4-cell stage embryos. Suppres-
O. In contrast, the efﬁciency of eFGF MOwas signiﬁcantly less than that of XWnt-8 MO, and
of defects in the expression of retinal marker Rx2A. XWnt-8 MO reverses the defects in Rx2A
MOs shows signiﬁcant effects, eFGFMOhas aweak rescue activity. Arrows in (D), (Q), (S) and
Fig. 7. FoxB1 collaborates with Oct-25 in the process of neural induction. (A–H) FoxB1 acts together with Oct-25 to promote neural development. Together with β-galmRNA, FoxB1
MO (34 ng; A and B), Oct-25 MO (8.6 ng; E and F), or a combination of both MOs (C and D) were injected unilaterally into both dorsal and ventral animal blastomeres of 8-cell stage
embryos. Total amount of injected MO (42.6 ng per embryo) was adjusted by adding Control MO in each experimental group. For rescue experiments, a mixture of MOs and either
Nmut-FoxB1 (1000 pg; G) or ΔBMPR mRNA (1000 pg; H) was injected as described above. Inhibition of both FoxB1 and Oct-25 function resulted in a marked reduction in the ex-
pression of Sox2 (arrowheads, C), and also caused the expression of epidermal keratin to extend into neural plate territory (arrowheads, D). Expression of Sox2 (A, C, E, G and H) and
epidermal keratin (B, D and F) analyzed by in situ hybridization is shown in purple and β-gal is stained in red. The injected side of the embryo is indicated by brackets. A, C, E, G and
H: dorsal views with posterior to the top; B, D and F: anterior (front) view with dorsal to the top. (I) FoxB1 is in part required for neuralization of the ectoderm by Oct-25. A mixture
of mRNA and MOs was injected into animal poles at the 4-cell stage: GR-Oct-25 mRNA (1000 pg), Nmut-FoxB1 mRNA (500 pg), Control MO (68 ng), and FoxB1 MO (68 ng). Ecto-
dermal explants were isolated at the blastula stage, treated with DEX to activate Oct-25 and cultured until early neurula (st. 16) or late neurula stage (st. 23). The QPCR data are
shown as arbitrary units normalized to ODC expression. (J) FoxB1 and Oct-25 form a regulatory network essential for neural induction processes, which resembles the motif of feed-
forward loop networks (K). See Discussion for details.
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support the idea that this factor regulates BMP signaling from gastrula
stages onwards, to pattern the ectoderm along the DV axis, thereby
promoting neural induction.
Nevertheless, loss-of-function analysis of FoxB1 indicated that it is
dispensable for neural induction per se and instead is required for the
AP patterning of neural tissue (Fig. 5). Intriguingly, however, FoxB1 is
not only located downstream of, but also functionally interacts with,
Oct-25 in the process leading to the establishment of the neural fate
of the ectoderm (Fig. 7). As depicted in Fig. 7J, we propose that a reg-
ulatory network consisting of FoxB1 and Oct-25 plays an importantrole in the establishment of neural tissue. In this network, Oct-25 ac-
tivates the expression of neural genes such as Sox2, as well as FoxB1,
which helps stimulate the expression of Sox2. As FoxB1 is dispensable
for neural induction unless Oct-25 is downregulated, and inhibition of
Oct-25 function moderately affects neural induction in the presence
of FoxB1, these two factors play an overlapping role in induction
and/or maintenance of neural tissue. The network consisting of
FoxB1 and Oct-25 resembles a feed-forward loop (FFL) network
(Fig. 7K) in which either a direct or an indirect path via an intermedi-
ate factor (Y) from the upstream inducer (X) is sufﬁcient to positively
regulate their target (Z) (Alon, 2006, 2007). It has been proposed that
26 K. Takebayashi-Suzuki et al. / Developmental Biology 360 (2011) 11–29this type of FFL network provides a means to protect against transient
loss of inducer and is utilized in a variety of different biological sys-
tems. We postulate that FoxB1 plays an important role in the forma-
tion of neural tissue by modulating BMP signaling together with Oct-
25, and possibly with other neural inducing signals, during embryo-
genesis. Because the expression of FoxB1 is regulated not only by
Oct-25 but also by the posteriorizing factors Wnts and FGFs (Gamse
and Sive, 2001), the network composed of Oct-25 and FoxB1 could
be inter-connected with other regulatory networks. These networks
could function as a buffer against ﬂuctuations in input signals result-
ing from environmental stresses and might act as a fail-safe mecha-
nism during early development.
The expression of FoxB1 is controlled by multiple genes acting at
early gastrulation and intensiﬁes after mid-gastrulation in the dorsal
ectoderm (Gamse and Sive, 2001; Supplemental Fig. 1). Moreover,
we demonstrated that BMP inhibition is a prerequisite for FoxB1 to
efﬁciently induce neural tissue (Figs. 2 and 4). These observations
suggest that FoxB1 is involved in relatively late steps of neural induc-
tion processes such as maintenance and patterning events. It has been
suggested that after initial neural induction, a “stabilization step” or
“maintenance phase” is needed for deﬁnitive neural fate (De Robertis
and Kuroda, 2004; Moody and Je, 2002; Stern, 2005; Stern et al.,
2006; Wills et al., 2010). We propose that FoxB1 may play a support-
ive rather than instructive role in the DV patterning of the ectoderm
by ﬁne-tuning BMP signaling, and thus is likely to contribute to the
maintenance phase of neural induction processes.
With regard to mechanisms of BMP inhibition by FoxB1, we found
that FoxB1 localizes to the nucleus (Figs. 1F and G) and preferentially
interacts with non-phosphorylatable Smad8 (Smad8AAVA) which
mimics unphosphorylated and recently dephosphorylated Smad8
(Fig. 1E). In the nucleus, FoxB1 has at least two opportunities to en-
counter unphosphorylated Smad8: ﬁrstly, it could bind to the unpho-
sphorylated form of Smad8 which is shuttling in and out of the
nucleus; secondly, upon ligand stimulation, phosphorylated Smad8
once translocated into the nucleus could then bind to FoxB1 after
being dephosphorylated by the Smad phosphatases known to be pre-
sent in the nucleus (Chen et al., 2006; Duan et al., 2006; Knockaert et
al., 2006). While these processes are not mutually exclusive and
others may also play a role, the association of Smad8 with nuclear-
localized FoxB1 would result in the nuclear retention of Smad8 and
therefore reduce the levels of cytoplasmic Smad8 available for phos-
phorylation/activation. In fact, we found that in the presence of
FoxB1, Smad8AAVA predominantly resides in the nucleus of ectoder-
mal cells at a higher frequency than in the absence of FoxB1 (Figs. 1G
and H). While nuclear sequestration of Smad has been reported with
other nuclear-localized Smad partners, FoxH1 and ATF3 (Hoodless et
al., 1999; Kang et al., 2003; Xu et al., 2002), it is interesting to note
that in contrast to FoxB1, FoxH1 has a binding preference for activat-
ed (presumably phosphorylated) Smads (Chen et al., 1997; Liu et al.,
1997; Randall et al., 2004). Therefore, the BMP inhibitory action of
FoxB1 represents a unique mode of regulation by Smad-associated
factors in the TGF-β signaling pathway. With regard to the speciﬁcity
of FoxB1 for non-phosphorylatable and phospho-mimicking forms of
Smad8, it is reported that the Caenorhabditis elegans FoxB homolog
LIN-31 interacts with a phospho-mimicking mutant form of SMA-3
(R-Smad homolog) more strongly than its non-phosphorylatable
form in the yeast two-hybrid system (Wang et al., 2005). In addition,
LIN-31 and SMA-3 function together in the formation of speciﬁc tis-
sue types. These observations are the opposite of what is observed
with Xenopus FoxB1; the reason for these differences is not certain,
but may reﬂect different context-dependent interactions involving
tissue- and/or species-speciﬁc cofactors. It has been reported that
the Fox family member FoxH1 possesses a Smad-interacting motif
(SIM) (Germain et al., 2000), as well as the Fast/FoxH1 motif (FM),
that are essential for interacting with active Smad2-Smad4 complexes
(Randall et al., 2004). Neither the SIM nor FM is conserved in XenopusFoxB1, but there is a possibility that FoxB1 interacts with Smad8
through other motifs. In future studies, it would be interesting to de-
termine which domain of FoxB1 is crucial for interacting with Smad8
and thereby regulating BMP signaling.
FoxB1 cooperates with the posteriorizing factors, Wnt and FGF, in the
establishment of the anterior–posterior axis
We found that FoxB1 not only regulates DV patterning of the ecto-
derm but also AP patterning by promoting the expression of posterior
neural markers and further suppressing anterior development. The
FoxB1-mediated suppression of anterior development was efﬁciently
rescued by XWnt-8 MO, while eFGF MO had only weak activity in this
regard (Fig. 6). XWnt-8 also rescued HoxB9 expression along the AP
axis in FoxB1 morphant embryos, and while eFGF alone did not
have this ability, it slightly augmented the effect of XWnt-8 (Fig. 5).
Based on these observations, we propose that XWnt-8 primarily me-
diates the function of FoxB1 in patterning the AP axis by imparting AP
positional value, and that FGFs may play a supportive role in cooper-
ation with Wnt ligands to promote posterior neural development
(Figs. 5 and 6). This view is also consistent with previous observations
obtained in chick neuroectoderm (Nordström et al., 2002).
Although the above results suggest that both XWnt-8 and eFGF lie
downstream of FoxB1 in the patterning of the AP axis, both Wnt and
FGF signals are capable of inducing FoxB1 expression in the ectoderm
(Gamse and Sive, 2001). Therefore, in addition to being effectors of
FoxB1, these signaling pathways could function upstream of FoxB1
to promote neural development and patterning. In addition, in the
presence of eFGF, FoxB1 was found to efﬁciently induce the expres-
sion of HoxB9 (Figs. 3 and 4), indicating that FoxB1 may also function
in parallel with eFGF. As such interactions have not been observed be-
tween FoxB1 and Wnts so far (data not shown), FoxB1 and FGF sig-
naling might be intimately linked in the formation of neural tissue.
The precise mechanisms of the interactions between FoxB1 and FGF
pathways are unclear at the moment; this would be a fruitful area
for future research because multivalent functions of FoxB1 including
neuralization and posteriorization overlap with FGFs.
Role of FoxB1 in the coordinated formation of DV and AP axes
The speciﬁcation of cell fate along DV and AP axes is thought to be
a coordinated process during early development (De Robertis, 2008;
Niehrs, 2010). Signaling crosstalk among several regulatory pathways
underlies this process and therefore it is rather difﬁcult to distinguish
contributions of regulatory molecules/pathways to each speciﬁcation
process. Our results suggest that FoxB1 regulates DV and AP pattern-
ing by modulating BMP, Wnt and FGF pathways, and that it is essen-
tial for the formation of posterior neural tissues. One could argue that
the loss of posterior neural identities in FoxB1 morphants is the result
of the reduction of neural speciﬁcation, an indirect effect from defects
in DV speciﬁcation. However, in dorsal ectodermal explant isolated
from FoxB1 morphants, the expression of the posterior neural
markers HoxB9 and HoxC6 was reduced without a reduction of the
general neural marker Sox2 (Fig. 5P). Therefore, it is plausible that
FoxB1 plays, at least in part, a direct role in the regulation of AP pat-
terning process, presumably via Wnt and FGF pathways. There are
several reasons that explain little inhibition of dorsal (neural) speciﬁ-
cation in FoxB1 morphants, while overexpression of FoxB1 promotes
neural induction. As shown in Fig. 7, FoxB1 is a part of the signaling
network that induces and maintains neural fate during early develop-
ment and other factors such as Oct-25 could compensate for the loss
of FoxB1. Another possibility is that while the loss of FoxB1 could en-
hance BMP signaling as expected from the results shown in Fig. 1, this
effect might be dampened by the reduced levels of the Wnt pathway
(Supplemental Fig. 10) which reinforces the BMP pathway in parallel
with a promotion of posterior fate via β-catenin (Fuentealba et al.,
27K. Takebayashi-Suzuki et al. / Developmental Biology 360 (2011) 11–292007). As FoxB1 cooperatively functions with other molecules, we
propose that FoxB1 plays a supportive, rather than instructive, role
in the formation of neural tissue and that it is potentially involved
in ﬁne-tuning of neural induction and patterning. In future studies,
it will be necessary to examine integrative regulation of coordinated
axis formation via signaling pathways by analyzing spatial and tem-
poral changes of interactions and expression of signaling components
including FoxB1 during early development.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.ydbio.2011.09.005.
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